ChipCare company

ChipCare’s mission is to bring lab-based medical tests to patients, enabling every person around the world to have easy access to state-of-the-art blood tests. The envisioned product entails two components: handheld reader and disposable test slide. The revenue will mainly be generated from sales of disposable test slides (consumables). Our proprietary detection technique enables testing of multiple diseases from a single drop of blood sample, including cell counting, protein/enzyme and pathogen detection. ChipCare’s solution to this problem is an integrated point-of-care testing and monitoring system to address the current clinical challenges in both resource rich and resource limited settings. It combines patient identification, blood testing, communication, and external quality management protocol. It is also a platform system that can be used to test different diseases from a single drop of blood.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Toronto, Ontario, Canada
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: $1M
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
http://twitter.com/zfraudshield
Register and Claim Ownership